Related Experiment Video
Updated: Jul 2, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Long-term effect of enhanced external counterpulsation on endothelial function in the patients with intractable
Mohammad Hashemi1, Marzieh Hoseinbalam, Majid Khazaei
1Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Insights
Enhanced external counterpulsation (EECP) acutely improves endothelial function in patients with ischaemic cardiomyopathy. However, these benefits on endothelial function do not persist long-term, returning to baseline one month after treatment cessation.
Area of Science:
- Cardiology
- Vascular Biology
- Noninvasive Cardiovascular Techniques
Background:
- Enhanced external counterpulsation (EECP) is a noninvasive pneumatic therapy known to benefit patients with coronary artery disease.
- Ischaemic cardiomyopathy presents challenges in managing cardiac function and vascular health.
Purpose of the Study:
- To evaluate the long-term impact of EECP on endothelial function in patients diagnosed with ischaemic cardiomyopathy.
- To assess changes in endothelium-dependent and -independent vasodilation following EECP therapy.
Main Methods:
- A cohort of 15 patients with ischaemic cardiomyopathy underwent a 7-week EECP treatment course (35 hours total).
- Endothelial function was assessed using flow-mediated dilation (FMD) for endothelium-dependent relaxation and nitroglycerine-mediated dilatation (NMD) for endothelium-independent relaxation.
- Measurements were taken before, during, and after the EECP course, with a follow-up assessment one month post-therapy.
Main Results:
- A significant improvement in FMD index was observed after 35 hours of EECP compared to baseline (10.95% vs. 7.40%, p<0.05).
- Nitroglycerine-mediated dilatation (NMD) showed no significant alteration during the EECP therapy.
- One month after completing EECP, the FMD index returned to baseline levels (7.51% vs. 7.40%, p<0.05), indicating a transient effect on endothelial function.
Conclusions:
- EECP demonstrates an acute positive effect on endothelial function in patients with ischaemic cardiomyopathy.
- The improvement in endothelial function appears to be temporary, suggesting it may not be the primary mechanism for any long-term benefits of EECP.
- Further research is needed to explore alternative mechanisms underlying the sustained effects of EECP in managing ischaemic cardiomyopathy.
Background:
Enhanced external counterpulsation (EECP) is a noninvasive, pneumatic technique that provides favourable effects in patients with coronary artery disease. The objective of this study was to describe the long-term effect of EECP on endothelial function in patients with ischaemic cardiomyopathy.
Method:
The study was performed in 15 patients with ischaemic cardiomyopathy. All subjects were treated with EECP 1-h per day, 5 days a week, over 7 weeks (totally 35h). Endothelium-dependent and -independent relaxation was assessed by flow-mediated dilation (FMD) and nitroglycerine-mediated dilatation (NMD). In each patient, FMD and NMD measurements were performed before, at midcourse (day 17th) and after completion of EECP course (day 35th). In addition, FMD index was assessed 1 month after completion of EECP therapy.
Results:
Results showed that EECP was associated with a significant improvement in FMD index after 35 hours of EECP (10.95+/-4.1% vs. 7.40+/-4.9% for baseline, p<0.05). NMD index didn't significantly alter during the EECP therapy. Also, 1 month after completion of EECP, FMD index returned to baseline (7.51+/-4.4% vs. 7.40+/-4.9%, respectively, p<0.05). EECP acutely improved endothelial function in ischaemic cardiomyopathic patients. However, after 1 month completion of treatment, endothelium-dependent vasorelaxation returned to baseline.
Conclusion:
It seems that improvement of endothelial function is not the main mechanism of long-term EECP treatment and other mechanisms should be considered.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Angina IV: Management
Angina V: Nursing Management
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
